Research and Treatment Development for SCA2

SCA2 or Spinocerebellar Ataxia 2 is a rare neuromuscular disease. The National Ataxia Foundation is proud to host this webinar presented by Dr. Sokol Todi on July 26, 2023. In "Research & Treatment for SCA2", he teaches us how the disease is studied and gives an overview of the current state of research and drug development. For more on SCA2, check out our previous webinar in the series, "All About SCA2" here:    • All About SCA2   For more information on Ataxia, please visit our website: https://www.ataxia.org Become a Free NAF member! https://bit.ly/JoinNAF Follow us on Social Media! NAF Facebook:   / ataxiafounda.  . NAF Twitter:   / naf_ataxia   NAF Instagram:   / ataxiafound.  . Ataxia Subreddit:   / ataxia   About the Speaker: Dr. Sokol V. Todi is a Professor in the Departments of Pharmacology and Neurology at Wayne State University School of Medicine and the Chair of the Department of Pharmacology. Dr. Todi’s laboratory investigates mechanisms of neurodegeneration and neuroprotection in age-dependent neurodegenerative diseases caused by misfolded proteins, with a particular focus on polyglutamine disease proteins. His laboratory has invested in SCA3 for over a decade, and has recently expanded into other SCAs, including SCA2, SCA7, and SCA17. The Todi laboratory uses cell culture and the fruit fly, Drosophila melanogaster, to model SCAs and other diseases and to find potential therapeutic entry points that include small molecules as well as lifestyle options, such as exercise. About the Series: NAF is producing a series of monthly educational webinars that focus on one type of Ataxia at a time. Each month we will feature a different type. Clinical experts will join us to take a look at the causes and symptoms of the disease, the typical diagnostic journey for those affected, and what to expect for clinical care. Research experts will teach us how the disease is studied and give an overview of the current state of research and drug development.